To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03081143
Title Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy (RAMIRIS)
Acronym RAMIRIS
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | DEU | AUT

Facility Status City State Zip Country Details
Ordensklinikum Linz GmbH, Barmherzige Schwestern Linz Upper Austria 4010 Austria Details
Landeskrankenhaus Feldkirch - Rankweil Rankweil Vorarlberg 6830 Austria Details
Wiener Neustadt, Landesklinikum Wiener Neustadt 2700 Austria Details
HELIOS Klinikum Bad Saarow Bad Saarow Germany Details
Charité - Universitätsmedizin Berlin Berlin Germany Details
HELIOS Klinikum Berlin Buch Berlin Germany Details
Klinikum Bielefeld Mitte Bielefeld Germany Details
Kliniken Essen Mitte Essen Germany Details
Krankenhaus Nordwest Frankfurt Germany Details
Hämatologisch-Onkologische Praxis Eppendorf (HOPE) Hamburg Germany Details
Ortenau Klinikum Lahr Germany Details
Universitäres Krebszentrum Leipzig Leipzig Germany Details
Technische Universität München Muenchen 81675 Germany Details
Universitätsklinikum Tübingen Tübingen Germany Details
Universitätsklinikum Ulm Ulm Germany Details
U.O. Oncologia Medica, Università Cattolica Sacro Cuore Rom Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field